Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMED.L Regulatory News (MED)

  • There is currently no data for MED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Appointment

30 Oct 2017 15:19

RNS Number : 0049V
Medaphor Group PLC
30 October 2017
 

 

MedaPhor Group plc

("MedaPhor" or the "Company")

 

Director Appointment

 

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces the appointment of Andrew Charles Barker as a Non-Executive Director effective immediately. Upon joining, Andrew will succeed David Baynes as Chairman of the Remuneration Committee, while David will retain the Chairmanship of the Company's Audit Committee.

 

Andrew, 59, has over 30 years' experience in senior management of technology and software businesses and in venture capital, having been involved in the early stages of internet computing with Sun Microsystems in Silicon Valley, later going on to help build Intel's venture arm in the UK.

 

He is an experienced NED and investor in early stage companies with disruptive technology. His portfolio has a med-tech focus and, in addition to his position as a Director of Intelligent Ultrasound Limited (acquired by MedaPhor on 6 October 2017, RNS number: 8775S), Andrew is the Chairman of Brainomix, a University of Oxford medical imaging spin out and a Partner of Anchard Associates LLP.

 

Riccardo Pigliucci, Chairman of MedaPhor, said: "I am very pleased to welcome Andrew to the Board. In addition to bringing a wealth of relevant experience, his appointment highlights the importance of Intelligent Ultrasound to the enlarged group and will facilitate its integration into MedaPhor."

 

Other than that set out above, there are no other matters that are required to be disclosed under Schedule 2 paragraph (g) of the AIM Rules in relation to the appointment of Mr. Barker.

Enquiries:

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Tel: +44 (0) 29 2075 6534

 

 

Cenkos Securities

Tel: +44 (0) 20 7397 8900

Bobbie Hilliam (Nominated Advisor)

 

Michael Johnson / Julian Morse (Corporate Broking)

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

About MedaPhor (www.medaphor.com)

 

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops advanced hi-fidelity haptic and manikin based training simulators, clinical image analysis software tools, augmented reality based needle guidance software and artificial intelligence based automated scanning software for all medical practitioners.

 Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:

 Ultrasound Simulation and Training

 

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Point-of-Care simulator platform (launching January 2018). Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound

 

Focuses on developing augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. ScanNav uses machine-learning based algorithms to automatically access and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGGQUUUPMGAU
Date   Source Headline
24th Oct 20062:34 pmRNSDirectorate Change
23rd Oct 20062:14 pmRNSHolding(s) in Company
13th Oct 20062:31 pmRNSHolding(s) in Company
12th Oct 20069:44 amRNSHolding(s) in Company
10th Oct 200610:37 amRNSDirector/PDMR Shareholding
5th Oct 20069:52 amRNSHolding(s) in Company
4th Oct 200610:53 amRNSDirector/PDMR Shareholding
2nd Oct 20062:57 pmRNSResult of EGM
6th Sep 20067:03 amRNSPlacing
6th Sep 20067:03 amRNSInterim Results
31st Aug 20069:09 amRNSHolding(s) in Company
27th Jul 20067:00 amRNSBoard Appointment
15th Jun 20064:26 pmRNSHolding(s) in Company
14th Jun 20062:58 pmRNSHolding(s) in Company
23rd May 20063:30 pmRNSAGM Statement
27th Apr 200610:00 amRNSPublication of Annual Report
13th Mar 200611:56 amRNSBlocklisting Interim Review
22nd Feb 20067:01 amRNSFinal Results
8th Feb 200610:29 amRNSAppointment of Adviser
4th Jan 20063:25 pmRNSDirectorate Change
29th Dec 20057:00 amRNSShipment of First Product
25th Nov 200512:33 pmRNSDirector/PDMR Shareholding
26th Oct 20057:00 amRNSDirectorate Change
6th Oct 20054:21 pmRNSDirector/PDMR Shareholding
29th Sep 20057:03 amRNSInterim Results
9th Sep 200510:49 amRNSAdditional Listing
8th Sep 20053:52 pmRNSBlocklisting Interim Review
9th Aug 20054:57 pmRNSTrading Statement
12th Jul 20057:00 amRNSAppointment to the Board
24th Jun 20054:39 pmRNSDirector Shareholding
3rd Jun 20057:00 amRNSTrading Statement
15th Apr 20057:00 amRNSPreliminary Results
15th Apr 20057:00 amRNSDirectorate Change
21st Mar 20057:00 amRNSUMC Silicon Wafer Production
7th Mar 20052:55 pmRNSBlocklisting
21st Jan 20059:14 amRNSAdjustment to Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.